factual
Fourth dose authorization based on antibody levels not outcomes
The fourth dose authorization (over age 50 in the US) was granted largely on the basis that it raises antibody levels back toward prior levels, not on proof that a healthy 51-year-old gets a further reduction in severe disease or hospitalization.
factualpending
Speaker
Vinay PrasadEvidence Quote
“no one in my mind has proven that person has a further reduction in severe disease or hospitalization by getting the fourth dose.”
Created: 6/13/2026, 12:17:03 AM
Your notes
Loading notes...